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Adaptive immune recognition is mediated by the binding of
peptide–human leukocyte antigen complexes by T cells. Positive se-
lection of T cells in the thymus is a fundamental step in the gener-
ation of a responding T cell repertoire: only those T cells survive that
recognize human peptides presented on the surface of cortical thy-
mic epithelial cells. We propose that while this step is essential for
optimal immune function, the process results in a defective T cell
repertoire because it is mediated by self-peptides. To test our hy-
pothesis, we focused on amino acid motifs of peptides in contact
with T cell receptors. We found that motifs rarely or not found in
the human proteome are unlikely to be recognized by the immune
system just like the ones that are not expressed in cortical thymic
epithelial cells or not presented on their surface. Peptides carrying
such motifs were especially dissimilar to human proteins. Impor-
tantly, we present our main findings on two independent T cell
activation datasets and directly demonstrate the absence of naïve
T cells in the repertoire of healthy individuals. We also show that
T cell cross-reactivity is unable to compensate for the absence of
positively selected T cells. Additionally, we show that the proposed
mechanism could influence the risk for different infectious diseases.
In sum, our results suggest a side effect of T cell positive selection,
which could explain the nonresponsiveness to many nonself pep-
tides and could improve the understanding of adaptive immune
recognition.
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positive selection
The human immune system has to differentiate between selfand nonself. The prerequisite of adaptive immune recognition
is the formation of the immunological synapse (1). This structure
is made up of human leukocyte antigen (HLA) molecules pre-
senting short peptide sequences to T cells (1). T cell receptors
(TCRs) recognize T cell exposed motifs (TCEMs) of peptide se-
quences (2–5). These are short, usually five amino acid–long
motifs in contact with the CDR3 region of TCRs and are not
involved in anchoring the peptides to HLA molecules (2–5).
Adaptive immune recognition is dependent on the presence of
peptide-specific T cells in the T cell repertoire (6). The T cell
repertoire is shaped by positive and negative selection steps in the
thymus (6). Positive selection takes place around cortical thymic
epithelial cells (cTECs) (6). cTECs present a special set of pep-
tides on the cell surface produced by the thymoproteasome and
cathepsin L (6–8). Recognition of these cTEC-specific peptides by
T cell precursors (called thymocytes) is essential for the formation
of a functioning T cell repertoire. Nonetheless, these peptides are
cleavage products of human proteins (6–9). Thymocytes recog-
nizing HLA-bound self-peptides survive, while others die by ne-
glect (7, 9). Positively selected T cells then go through negative
selection: T cells binding self-peptide–HLA complexes with high
affinity are deleted from the repertoire, referred to as central
tolerance (6).
The positive selection of T cells is an essential step in the
formation of a responsive T cell repertoire. It has been suggested
that both the CD4+ and CD8+ T cell repertoires are skewed to
greater self-reactivity and that T cells that bind self-peptides
stronger also bind the foreign agonist peptides more effectively
(9–11). In other words, self-peptides mediating positive selection
can be considered as a “test set” selecting T cells that recognize
foreign peptides with higher effectivity. However, is there any
negative consequence of this mechanism?
We propose a fundamental side effect of T cell positive se-
lection on the recognition of nonself peptides: as positive selection
is mediated by self-peptides, a large fraction of nonself peptides is
not recognized by the immune system even if T cells are cross-
reactive. To test our hypothesis, we focused on the TCEMs of
HLA class I (HLA-I) restricted peptides. As T cell positive selection
is mediated by TCEMs of self-peptides, we expected that it is less
likely to find specific T cells in the repertoire for TCEMs that are 1)
very rare or missing from human proteins, 2) not expressed in, or 3)
not presented on the surface of cTECs. Accordingly, we expected
that peptides carrying such motifs are less immunogenic. We
demonstrate the predictions of our hypothesis on two nonoverlap-
ping T cell activation datasets and provide more direct evidence by
examining naïve CD8+ T cell repertoires of healthy individuals.
Although it is widely accepted that nonself peptides that are highly
dissimilar to human proteins are more immunogenic (12–16), we
found that the dominantly nonimmunogenic peptides having rare
Significance
It is well established that peptides that are dissimilar to human
proteins are more immunogenic. However, the immune system
is still unable to recognize a large fraction of highly dissimilar
peptides found in a wide variety of pathogens. We propose
that this phenomenon could be explained by the mechanism of
T cell positive selection. During this process, only those cells
survive that recognize human peptides on the surface of thy-
mic epithelial cells. As self-peptides mediate positive selection,
the immune system is unable to recognize many nonself pep-
tides, most of which are highly dissimilar to human peptides.
Author contributions: B.K., L.K., andM.M. designed research; B.K., G.M.B., B.T.P., L.A., and
M.M. performed research; M.M. contributed analytic tools; B.K., G.M.B., B.T.P., L.A., and
M.M. analyzed data; B.K. and M.M. wrote the paper; L.K. provided supervision and fund-
ing acquisition; and M.M. provided supervision and project administration.
The authors declare no competing interest.
This article is a PNAS Direct Submission.
This open access article is distributed under Creative Commons Attribution License 4.0
(CC BY).
1To whom correspondence may be addressed. Email: manczinger.mate@med.u-
szeged.hu.
This article contains supporting information online at https://www.pnas.org/lookup/suppl/
doi:10.1073/pnas.2100542118/-/DCSupplemental.
Published September 10, 2021.





















TCEMs were more dissimilar to human proteins than immunogenic
ones. Such peptides dominated the proteome of many intracellular
pathogens, and their presentation by HLA-I molecules was associ-
ated with an increased risk of infectious diseases. Our results sug-
gest that the self-mediated positive selection of T cells generates a
“blind spot” in adaptive immune recognition with implications on
the susceptibility to infectious diseases.
Results
Dataset Assembly. To test the predictions of our hypothesis, we
focused on the immunogenicity of peptides that are presented by
HLA-I molecules, and thus, the lack of T cell response cannot be
explained by missing antigen presentation. We collected T cell
activation data for nonhuman peptides from the Immune Epitope
Database (IEDB) (17) and assembled two nonoverlapping data-
sets using different criteria (SI Appendix, Fig. S1 and Dataset S1).
In the first dataset, we predicted the binding of each peptide to
the reported HLA allele and excluded the ones whose HLA-
binding was not confirmed by prediction. To note, this ap-
proach has already been used by previous studies focusing on
peptide immunogenicity (5). In the case of the second dataset,
we aimed to control for certain confounding factors that could
bias the analysis. First, the computational prediction of HLA-
binding can be inaccurate especially for certain HLA alleles (18,
19). Second, previous works have suggested that the overrepre-
sentation of highly similar sequences due to collection bias in the
IEDB could influence the analysis results (20, 21). Consequently,
we kept allele–peptide pairs if the binding of the peptide to the
reported HLA allele was also verified empirically and excluded
similar sequences using an iterative method (Methods and SI
Appendix, Fig. S1). Importantly, we also excluded peptides hav-
ing controversial assay results or discordant results for different
HLA alleles from both datasets. We defined peptides with ex-
clusively negative assay results as nonimmunogenic and peptides
with dominantly positive assay results as immunogenic (for de-
tailed curation and filtering steps, refer to Methods and SI Ap-
pendix, Fig. S1).
The number of immunogenic and nonimmunogenic peptides
was 1,093 and 2,287 in the first dataset and 360 and 275 in the
second one. Peptides in the second dataset had high diversity and
covered the sequence space more homogeneously after excluding
similar sequences (SI Appendix, Fig. S2). We analyzed the two
nonoverlapping datasets in parallel to present our findings on a
large number of peptides (dataset 1) and to ensure that they are not
confounded by computational prediction or the presence of similar
sequences (dataset 2).
TCEMs Occurring Very Rarely or Missing from Human Proteins Are
Less Likely to Be Immunogenic. The positive selection of T cells
is mediated by peptide sequences found in the human proteome.
Certain amino acids of presented peptides are buried in the
binding pockets of HLA molecules, and only five amino acids are
in contact with TCRs (2–5). These sequence motifs mediate the
recognition of presented peptides (2, 22, 23) and, consequently,
the positive selection of T cells in the thymus. We expected that
motifs very rarely or not found in the human proteome are less
likely to be immunogenic because specific T cells are potentially
missing from the repertoire as their precursors did not survive
positive selection. Similarly to previous studies (2, 4, 22), we
defined TCEMs as five amino acid–long sequences between the
anchoring positions of presented peptides (Methods). We then
determined their frequency in the reference human proteome.
We aimed to use TCEM frequency in human proteins as a proxy
of their presentation on the cell surface. The prevalence of
TCEMs in human proteins showed a long-tailed distribution: a
large fraction of motifs was rarely or not found in the human
proteome, but many still reached high frequencies (SI Appendix,
Fig. S3). Next, we collected data of immunopeptidomics studies
(Dataset S2) and found that the frequency of TCEMs in human
proteins can accurately predict their occurrence in HLA-I–bound
peptides on the cell surface (SI Appendix, Fig. S4). Importantly,
the analysis suggested that TCEMs found less than four times in
human proteins are unlikely to be presented on the cell surface
(SI Appendix, Fig. S4).
In line with expectation, nonimmunogenic peptides contained
TCEMs that are very uncommon or not found in the human
proteome (Fig. 1A). Accordingly, motifs occurring less than four
times in the human proteome were less likely to be immunogenic
than others. (Fig. 1D). The result suggests that TCEMs need to
occur in sufficient numbers in human proteins to be recognized by
the immune system. Otherwise, specific T cells are potentially absent
from the repertoire as their precursors have not survived positive
selection.
TCEMs That Are Not Expressed in cTECs Are Less Likely to Be
Immunogenic. In the subsequent analyses, we focused on motifs
occurring at least once in the human proteome. It was reported
that the HLA-I presentation of peptides is highly dependent on
the expression of the encoding gene (25). We assumed that
TCEMs encoded by genes having low or undetectable expression
in cTECs cannot mediate the positive selection of specific T cells.
At the same time, we did not expect an immune response to
TCEMs encoded by abundantly expressed housekeeping genes,
because the response to these TCEMs may be blocked by central
or peripheral immune tolerance (26, 27). In sum, we expected a
bimodal relationship between the expression of TCEM-encoding
genes and immunogenicity. We downloaded gene expression data
of human cTECs from a recent study (28). For each TCEM, we
determined the proteins containing its sequence. We then calcu-
lated the median expression of genes encoding these proteins to
approximate the chance for a given TCEM of being expressed in
cTECs. To examine the potentially bimodal relationship between
TCEM expression and T cell activation, we plotted the probability
for a TCEM of being immunogenic as a function of its expression
using lowess smoothing (Fig. 1B). We also examined the distri-
bution density of TCEM expression in the immunogenic and
nonimmunogenic peptide groups separately (Fig. 1B). We found
that in line with expectation, TCEMs having either low or high
expression in cTECs are similarly less likely to activate T cells than
the ones in the medium expression group (Fig. 1 B and D). These
results suggest absent T cell responses to TCEMs that are not
expressed at the site of T cell positive selection. As expected,
TCEMs in the high expression group were more likely to be found
in proteins encoded by housekeeping genes (SI Appendix, Fig. S5).
TCEMs That Are Not Presented on cTECs after Proteasomal Cleavage
Are Less Likely to Be Immunogenic. Even if a given TCEM is
expressed in cTECs, proper proteasomal cleavage is essential for
its presentation on the cell surface by HLA molecules. Protea-
somal cleavage is special in cTECs (6, 8, 29). Thymoproteasomes
are exclusively expressed in these cells and are responsible for the
generation of peptides that mediate the positive selection of
T cells. In contrast with constitutive and immunoproteasomes,
thymoproteasomes have a reduced ability to cleave peptide bonds
after hydrophobic amino acids (i.e., they have lower chymotrypsin-
like activity) (8). A previous study reported the amino acid pref-
erence of thymo- and immunoproteasomes around their cleavage
sites (8). Using the presented data, we approximated the proba-
bility of thymo- and immunoproteasomal cleavage at each position
of the reference human proteome. We then calculated a score
associated with the chance of a given TCEM being generated after
thymoproteasomal cleavage and, thus, presented on the surface of
cTECs (Methods and SI Appendix, Fig. S6). We expected lower
immunogenicity for TCEMs that are less likely to be presented on
the surface of cTECs after thymoproteasomal cleavage. At the
same time, we expected no effect of immunoproteasomal cleavage
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on immunogenicity because the immunoproteasome has only
minor importance in cTECs (8). In line with expectation, TCEMs of
immunogenic peptides were more likely to be generated by thymo-
proteasomal cleavage than nonimmunogenic ones, while immuno-
proteasomal cleavage did not affect immunogenicity (Fig. 1C).
Accordingly, TCEMs that are unlikely to be presented on cTECs
were less immunogenic (Fig. 1D).
The Robustness of Results. We reported three lines of evidence
suggesting that the positive selection of T cells results in a de-
fective T cell repertoire with implications on the recognition of
nonself peptides. First, TCEMs that are very rare or not found in
human proteins are less likely to be immunogenic (Fig. 1 A and
D). Second, the scarce expression of TCEMs in cTECs is also
associated with lower immunogenicity (Fig. 1 B and D). Third,
TCEMs that are improbably generated by the cTEC-specific thy-
moproteasome are less likely to be immunogenic (Fig. 1 C and D).
These effects on immunogenicity held in multivariate logistic
regression models, indicating that they are not confounded by
and independent of each other (SI Appendix, Fig. S7 and Table
S1). Similarly, the effect of these attributes was additive: rare
TCEMs having low expression in cTECs and low thymoprotea-
somal cleavage score were less likely to be immunogenic than
TCEMs having only one or two of these attributes (SI Appendix,
Table S2).
Next, we tested whether our findings are confounded by a
single amino acid with a peculiar effect on immunogenicity. First,
we examined the prevalence of the 20 amino acids in immuno-
genic and nonimmunogenic TCEMs. The most significant dif-
ference was found for tyrosine and phenylalanine enriched in
nonimmunogenic motifs and glycine and alanine enriched in
immunogenic ones (SI Appendix, Table S3). This is in line with
expectation as the former amino acids are rarely while the latter
ones are commonly found in human proteins (SI Appendix, Table
S3). Surprisingly, tryptophan, the rarest amino acid, was more
common in immunogenic TCEMs, which can be explained by its
major role in peptide immunogenicity (30–32). Reassuringly, this
phenomenon had no effect on our results as all findings
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TCEM frequency < 4 TCEM expression < 15% TCEM expression > 75% Thymoproteasomalcleavage score < 25%
Immunoproteasomal
cleavage score < 25%
Dataset 1
OR (P) 0.68 (3.2 x 10
-7
) 0.71 (0.002) 0.74 (0.001) 0.77 (0.004) 1.01 (0.89)
Dataset 2
OR (P) 0.61 (0.003) 0.48 (0.003) 0.55 (0.003) 0.67 (0.041) 1.00 (1.00)
D
Fig. 1. Peptide immunogenicity is influenced by TCEM frequency in human proteins (A), TCEM expression in cTECs (B), and TCEM presentation on cTECs (C).
(A) The plot indicates the number of times immunogenic (+, n = 1,093 and 360 in datasets 1 and 2, respectively) and nonimmunogenic (−, n = 2,287 and 275 in
datasets 1 and 2, respectively) TCEMs found in human proteins. In both datasets, TCEMs of immunogenic peptides were found more times in human proteins
than TCEMs of nonimmunogenic ones. Outliers are not shown for visualization purposes. (B) The upper plots show the probability of a TCEM being im-
munogenic as the function of its expression in cTECs. The curves were fitted using lowess regression (24). The lower plots indicate the probability density of
the expression of immunogenic (n = 997 and 326 for datasets 1 and 2, respectively) and nonimmunogenic (n = 2,040 and 247 for datasets 1 and 2, respectively)
TCEMs. For visualization purposes, gene expression values were transformed by calculating their percentile rank. Vertical dashed lines indicate cutoff values
used for OR calculation in D. (C) The likelihood of TCEM formation after thymoproteasomal (Left) and immunoproteasomal (Right) cleavage is shown. TCEMs
of immunogenic peptides were more likely to be generated and presented after thymoproteasomal but not immunoproteasomal cleavage. n = 997 and 327
for immunogenic and 2,046 and 248 for nonimmunogenic TCEMs in datasets 1 and 2, respectively. Outliers are not shown for visualization purposes. (D)
Peptides were classified based on their TCEMs’ frequency in human proteins, expression in cTECs, and thymo- or immunoproteasomal cleavage scores. TCEMs
found rarely in the human proteome, having low expression in cTECs or low thymoproteasomal cleavage score were less likely to be immunogenic. P values of
two-sided Fisher’s exact tests are shown. In A and C, the P values of two-sided Wilcoxon’s rank-sum tests are indicated. On A and C, the bottom and top of
boxes indicate the first and third quartile, horizontal lines indicate median, and vertical lines indicate first quartile − 1.5*IQR and third quartile + 1.5*IQR. DS1:
dataset 1, DS2: dataset 2.
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remained significant when we iteratively repeated the analysis by
excluding TCEMs containing certain amino acids (SI Appendix,
Table S3). The hydrophobicity of TCR contact residues is
reported to influence peptide immunogenicity (33) and could
confound our results. The effect of all TCEM attributes on im-
munogenicity remained significant when controlling for hydro-
phobicity in logistic regression models (SI Appendix, Fig. S8).
Finally, it is reported that peptides bind to certain HLA var-
iants with secondary anchors in their TCEM region (34). We
determined these HLA variants using data from a recent
immunopeptidomics study (35) (Methods). All of our results held
after excluding peptides that bind to all reported HLA variants with
secondary anchors at the TCEM region (n = 69 and 16 in datasets 1
and 2, respectively; SI Appendix, Fig. S9 and Dataset S1).
The Frequency, Expression, and Presentation of TCEMs Determine the
Prevalence of Specific Naïve CD8+ T Cells in the Repertoire. To
confirm our previous findings, we aimed to directly demonstrate
the predictions of our hypothesis. Specifically, we expected that
it is less likely to find a given naïve T cell in the repertoire that is
specific for infrequent TCEMs in human proteins, for TCEMs
not expressed in cTECs, or for TCEMs not presented on the
surface of cTECs. We used recently published data on the
peptide-specificity of naïve CD8+ T cells in the repertoire of
healthy individuals (Methods) (36). The authors reported the
prevalence of naïve CD8+ T cells specific for any of the examined
296 nine amino acid–long (9-mer) SARS-CoV-2 peptides in the
repertoire of 27 individuals. In the case of each individual, we
focused on sequences that were bound by at least one of their
HLA-I alleles (Methods), because we expected to find specific
T cells for HLA-presented peptides only. We grouped the pep-
tides based on the prevalence, expression, and proteasomal
cleavage scores of their TCEMs as described previously for T cell
activation datasets. For each individual and in each peptide group,
we determined the fraction of HLA-presented peptides that are
recognized by at least one TCR in the repertoire. Specific naïve
CD8+ T cells were less likely to be present for rare than nonrare
TCEMs in the repertoire of healthy individuals (Fig. 2A). Simi-
larly, it was less likely to find specific T cells for TCEMs having
either negligible or overly high expression in cTECs (Fig. 2B).
Moreover, TCEMs with low thymoproteasomal cleavage scores
were less likely to be associated with the presence of specific
T cells in the repertoire (Fig. 2C), while the immunoproteasomal
cleavage score did not show this relationship (Fig. 2D). In sum,
our findings for T cell repertoires of healthy individuals confirmed
the presented results on the T cell activation datasets.
Decreased Immunogenicity of Overly Dissimilar Peptides to Human
Proteins. Our hypothesis predicted a rather provocative rela-
tionship: in contrast with expectation, overly dissimilar peptides
are not recognized by the immune system, because self-peptides
mediate the positive selection of specific T cells. To test this pre-
diction, for each peptide in the T cell activation datasets, we de-
termined its most similar counterpart in the human proteome using
the basic local alignment search tool (BLAST) software as in pre-
vious studies (37, 38) (Methods). As expected, peptides with very
rare TCEMs (occurring zero to three times) in the human pro-
teome had lower similarity to human proteins than other peptides
(Fig. 3A). Accordingly, overly dissimilar peptides of datasets 1 and 2
were less likely to be immunogenic just like highly similar ones
(Fig. 3B). Importantly, we found the same relationship when ana-
lyzing dissimilarity values of an independent study published re-
cently (37) (SI Appendix, Fig. S10). To corroborate these results, we
analyzed the self-similarity of SARS-CoV-2 peptides. Reassuringly,
we found naïve CD8+ T cells that are specific for highly dissimilar
peptides in the repertoire of fewer individuals (Fig. 3C).
We conclude that while a given level of peptide dissimilarity to
human proteins is essential for self-nonself discrimination, overly
dissimilar peptides are less likely to be recognized by the immune
system, because specific T cells are not present in the repertoire.
Cross-Reactivity Is Not Able to Compensate for the Side Effect of
Self-Mediated Positive Selection of T Cells. We propose that the
mechanism of positive selection results in a defective T cell
repertoire. Is the cross-reactivity of TCRs able to compensate for
these defects? To answer this question, we first created two groups
of TCEMs (Fig. 4A). The first group consisted of motifs in datasets
1 and 2, for which we assumed that it is the least likely to find
specific positively selected T cells in the repertoire (n = 43, they
were nonimmunogenic, found less than four times in the human
proteome, and had low expression in cTECs and low thymopro-
teasomal cleavage score; SI Appendix, Table S2). The second group
consisted of all possible TCEM sequences (n = 323,470), for which
the presence of specific T cells in the repertoire is likely: they were
found more than three times in the human proteome, expressed in
cTECs, and had normal thymoproteasomal cleavage score. For
each TCEM in the first set, we calculated its BLOSUM62 (blocks
substitution matrix 62) similarity to every TCEM in the second set
to explain their proximity in sequence space (Fig. 4A).
Next, we estimated the level of TCR cross-reactivity in the
sequence space of TCEMs. We downloaded empirical data from
a recent study. The authors measured the binding strength of the
well-known NY-ESO-1 epitope to TCR C259, when sequentially
replacing every amino acid in different positions of the epitope
(23). We determined the BLOSUM62 similarity between the
TCEM of the original and the modified peptide sequences and
found a strong positive correlation between the similarity of the
original to the modified TCEM and the peptide binding strength
to TCR C259 (Fig. 4B).
We then aimed to determine a TCEM similarity cutoff value,
under which the binding to the TCR is too weak to induce T cell
activation (Fig. 4A). To this end, we examined the relationship
between the TCR binding strength and the activation of T cells
which was reported in the same study. We fixed less than 10% of
the original binding strength as insufficient binding because the
ability of peptides to activate T cells was negligible below this cutoff
(Methods). We found that the similarity between the modified and
the original TCEM can accurately predict whether the peptide will
be bound by the TCR strong enough to cause T cell activation
(Fig. 4C). We then used an established “cost–benefit” method (39)
to determine the optimal TCEM similarity cutoff for binding
(Methods). We considered this value as the lowest similarity between
two TCEM sequences that can be bridged by the examined TCR.
Reassuringly, we got a very similar cutoff value, when using data of
an independent study on the A6 TCR and its target epitope, the Tax
peptide of HTLV-1 (40) (SI Appendix, Fig. S11 andMethods). As the
result of this analysis, we had an estimate on the magnitude of cross-
reactivity of a given TCR in sequence space.
We then determined whether T cells that are specific for
TCEMs in the second group are able to bind TCEMs in the first
group (Fig. 4D). We found that only an insignificant minority
(ranging from 0.0006 to 0.043% for TCEMs in the first group,
median = 0.015%) of similarity values reached the previously
determined cutoff values of T cell cross-reactivity (Fig. 4D). This
result suggests that T cells in the repertoire (specific for TCEMs in
the second group) are not likely to recognize TCEMs, whose
recognition is negatively affected by self-mediated positive selec-
tion (i.e., TCEMs in the first group). Although the result is in-
dicative, it is important to highlight that we inferred cross-
reactivity based on the data for two TCRs, and the results need
future validation using data of more TCRs.
Positive Selection of T Cells and Susceptibility to Infections. The
adaptive immune recognition of pathogen-associated peptides
is essential for the initiation of an effective immune response.
Our results suggest that many such peptides are potentially
4 of 11 | PNAS Koncz et al.
https://doi.org/10.1073/pnas.2100542118 Self-mediated positive selection of T cells sets an obstacle to the recognition of nonself
nonimmunogenic, because specific T cells are not found in the
repertoire of CD8+ T cells. We aimed to determine the fre-
quency of peptides in proteins of intracellular pathogens that
could be affected by the side effect of T cell positive selection to
some extent. To this end, we downloaded reference proteomes of
50 common intracellular pathogens. In the proteome of each spe-
cies, we determined the prevalence of TCEMs that are either rare
or not found in human proteins, not or lowly expressed in cTECs, or
unlikely to be presented after thymoproteasomal cleavage (we call
them np-TCEMs hereafter, referring to TCEMs for which we ex-
pect to find specific positively selected T cells with lower probabil-
ity). We found that the frequency of np-TCEMs is ranging from 58
to 71% in different species. (Fig. 5A and Dataset S3).
The high prevalence of np-TCEMs could hinder immune
recognition, especially when only a few peptides of the pathogen
are presented to T cells. This might be the case when either the
proteome of the given pathogen is small and/or the given HLA
allele has a narrow binding repertoire. To this end, we predicted
the binding of all 9-mer peptides to common HLA-I alleles
(Methods). For each allele-species pair, we calculated the fraction
of np-TCEMs in the presented peptides and visualized the results
on a heatmap (Fig. 5B). As expected, the fraction of presented
peptides with np-TCEMs was highly variable between HLA alleles
when the pathogens had small proteomes (Fig. 5C). This group of
pathogens was dominated by viruses, like Human parvovirus B19,
Hepatitis viruses, Human papillomavirus, etc. On the contrary,
HLA alleles presented a similar fraction of np-TCEMs from the
large proteomes of protozoal and bacterial species (Fig. 5C).
We expected that the fraction of HLA-presented np-TCEMs
could influence disease risk. To this end, we carried out litera-
ture mining to find HLA association meta-analysis data (Meth-
ods). We found such data for chronic hepatitis B (41), human
papillomavirus (42), and dengue virus (43) infection, and Hep-
atitis C viral persistence after IFN-alpha therapy (44). We se-
lected allele groups with positive or negative associations and
determined the prevalence of np-TCEMs in HLA-bound pep-
tides of the causative pathogens. In contrast with protective al-
leles, risk HLA allele groups bound peptides with dominantly np-
TCEMs (Fig. 5D).
These results suggest that the proposed side effect of T cell
positive selection influences the adaptive immune recognition of
intracellular pathogens.
Discussion
The prevalence of specific T cells in the repertoire is essential for
adaptive immune recognition of HLA-presented peptides. It has
been suggested that during positive selection, self-peptides on
the surface of cTECs can be considered as a test set for thy-
mocytes: cells that recognize these peptides survive and poten-
tially recognize nonself peptides more effectively. Consequently,
these cells dominate the immune response to the foreign anti-
gens (9–11). We propose that the nonresponsiveness to many
nonself peptides can also be explained by the mechanism of
T cell positive selection because it is mediated by self-peptides.
In other words, self-mediated positive selection has a negative
trade-off on the recognition of foreign peptides. Importantly, our
results suggest that T cell cross-reactivity is unable to compen-
sate for this negative consequence of positive selection (Fig. 4).
We presented three lines of evidence supporting our hypoth-
esis on two reliable and nonoverlapping peptide sets (Fig. 1). We
focused on the five amino acid–long TCEM region of peptides,
because numerous studies suggested that self–nonself discrimi-
nation is governed by these short motifs (2–5). Importantly, our
analysis on TCR cross-reactivity supports these findings: the
TCEM sequences of the modified NY-ESO-1 peptides alone
were able to determine the binding of the peptide to the TCR
C259 (Fig. 4B). At the same time, it has been at issue how such
short peptides can make it possible for the immune system to
differentiate between self and nonself peptides (2, 45). Namely,
human peptides contain around 75% of all possible pentamer




















































































































Fig. 2. Specific naïve CD8+ T cells were less likely to be present for TCEMs found rarely in human proteins (A), having low expression in cTECs (B) or low
thymoproteasomal cleavage score (C), while there was no relationship between immunoproteasomal cleavage score and the prevalence of CD8+ T cells (D).
The vertical axes represent the fraction of peptides, for which specific T cells were detected. Point pairs (or triplets on B) indicate values belonging to a given
individual (n = 22). Two-sided P values of paired Wilcoxon’s rank-sum tests are shown. TCEMs were stratified into expression groups based on tertiles and into
thymoproteasomal (TP) or immunoproteasomal (IP) cleavage score groups based on the first quartile. The bottom and top of boxes indicate the first and third
quartile, horizontal lines indicate median, and vertical lines indicate first quartile - 1.5*IQR and third quartile + 1.5*IQR.
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sequences (2) (73.1% in our analysis) that largely overlap with
the ones found in commensal and pathogenic bacteria (2). Our
findings suggest that the overlap between self and nonself motifs
is far from being disadvantageous; in fact, it is crucial for the
positive selection of T cells that are specific for foreign peptides.
In other words, the overlap between motifs makes it possible to
recognize nonself.
It is an important issue to be clarified whether our findings are
affected by regulatory T cell (Treg) activation. Namely, the
positivity of T cell assays in our in vitro datasets could reflect
the activation of Treg cells to some extent, which could explain
the positivity of assays for self-similar peptides. However, peptide
immunogenicity in our datasets is supported by dominantly IFN-
gamma enzyme-linked immune absorbent spot (ELISpot) assays
(Dataset S1). Although a small subset of induced Treg cells is able
to produce IFN-gamma (46), clear positivity of IFN-gamma
ELISpot assays is predominantly associated with inflammatory
but not tolerogenic responses (38). Consequently, it is not likely
that our results are confounded by Treg cell activation.
We aimed to support our hypothesis with direct evidence by
examining naïve CD8+ T cell repertoires of healthy individuals
(Fig. 2). The results suggest that self-mediated positive selection
has a negative effect on the prevalence of SARS-CoV-2 peptide-
specific T cells in the repertoire (Fig. 2). Importantly, it has al-
ready been suggested that “holes” in the T cell repertoire hinder
the recognition of certain pathogens (47–50), and the studies
explained the presence of such holes by central tolerance (47,
50). On the other hand, Yu et al. suggested that there are no
significant holes in the repertoire, because clonal deletion affects
only the most self-reactive T cells (51). Consequently, every pos-
sible HLA-presented peptide could be recognized by T cells, but
many T cells are anergic due to immune tolerance mechanisms.
However, our results suggest that the self-dependent positive se-
lection of T cells causes gaps in the immune recognition of nonself
peptides potentially through a biased T cell repertoire.
We also estimated the fraction of peptides in pathogens whose
recognition could be affected by self-mediated positive selection
to some extent. A significant proportion of peptides—varying
between 58% and 71% in different species—fell into this cate-
gory (Fig. 5A). If we also consider that around one-third of
nonself peptides are indistinguishable from self-ones due to high
similarity (52), it is not surprising that at least 50% of HLA-
A*02:01–presented vaccinia and HIV sequences were reported
to be nonimmunogenic in previous studies (47, 52, 53). At the
same time, which peptides are presented to the T cells depends
on the specificity of HLA alleles. We showed that HLA alleles
that predominantly present peptides whose recognition is po-
tentially hindered by self-mediated positive selection are asso-
ciated with risk for certain infections (Fig. 5D). To note, a similar
mechanism could also explain variable responses to vaccines
which need further investigation.
Finally, our results do not support a common interpretation of
self-nonself discrimination, which suggests that the more dis-
similar a peptide to self, the more likely it is to be immunogenic
(12–15). We showed that the more dissimilar a peptide to human
proteins, the less likely it is to find its TCEM in the human
proteome (Fig. 3A). Consequently, specific positively selected
T cells are potentially absent from the repertoire above a level of
dissimilarity (Fig. 3 B and C and SI Appendix, Fig. S10). We
conclude that although a certain level of dissimilarity is essential
for the discrimination of self and nonself, overly dissimilar pep-
tides are potentially not recognized by the immune system (Fig. 6).
While our results indicate the importance of this blind spot in the
immune response to infections, it is a question to be clarified in
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Fig. 3. Overly dissimilar peptides to human proteins are less immunogenic. (A) Peptides in datasets 1 and 2 with TCEMs found less than four times in human
proteins are less similar to the closest hit in the human proteome. (n = 1,706 and 2,309 in the 0–3 and 4− TCEM frequency groups, respectively) Outliers are
not shown for visualization purposes. (B) Peptides in datasets 1 and 2 were pooled and stratified into 25 groups based on similarity. In each group, the ratio
between immunogenic and nonimmunogenic peptides was calculated. Groups are shown in increasing order of similarity. The horizontal axis indicates the
mean similarity in the given group. The vertical dashed line indicates the group having the highest fraction of immunogenic peptides. The curve was fitted
with a cubic smoothing spline method in R (Methods). Background shading represents the similarity ranges of peptide groups on C. (C) T cells specific for
overly dissimilar peptides were found in the repertoire of fewer individuals. Peptides were stratified into sequence similarity groups based on the median
value (n = 149 and 147 in the lower and higher similarity groups, respectively). The similarity ranges are also indicated on B with background colors. Note that
the dataset of SARS-CoV-2 peptides did not include peptides that are highly similar to human proteins. On A and C, P values of two-sided Wilcoxon’s rank-sum
tests are indicated. The bottom and top of boxes indicate the first and third quartile, horizontal lines indicate median, and vertical lines indicate first
quartile − 1.5*IQR and third quartile + 1.5*IQR.
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Fig. 4. TCR cross-reactivity is not likely to compensate for the defects in the T cell repertoire. (A) Schematic diagram of the analysis. To determine whether
T cell cross-reactivity is able to bridge defects in the repertoire, we created two groups of TCEMs (I). The first group consisted of motifs, for which we assumed
that it is the least likely to find specific positively selected T cells in the repertoire (marked with red color on the figure). The second group consisted of all
TCEMs, for which we expected to find specific T cells in the repertoire (marked with green color on the figure). We calculated the pairwise similarity between
the members of the two TCEM groups (II). The higher the similarity between two TCEMs, the closer they reside in the sequence space resulting in smaller
distance (d) values. Next, we estimated the level of T cell cross-reactivity in TCEM sequence space (III). We defined cross-reactivity as the lowest similarity
between a given TCEM sequence and the TCR’s cognate TCEM sequence that is needed for a reasonable TCR binding strength and T cell activation. Finally, we
determined the number of cases when members of the first and second groups are close enough to be recognized by the same TCR. (B) The amino acids of the
NY-ESO-1 epitope were sequentially changed, and the binding strength to TCR C259 was measured in a previous study (23). The relative binding strength of
the modified (n = 135) and the original peptide to TCR C259 is shown as a function of BLOSUM62 similarity between their TCEM sequences. The horizontal line
indicates 10% of the original binding value, which was considered as a cutoff for improbable binding (Methods). Spearman’s rho and the P value of a two-
sided correlation test are indicated. The red line indicates a smooth curve fitted using a cubic smoothing spline method in R (Methods). (C) The ROC curve
demonstrates the accuracy of BLOSUM62 similarity in classifying peptides into binding and nonbinding (i.e., lower than 10% of original binding) groups. AUC:
area under the curve. (D) The density of all similarity values (n = 13,909,210) between TCEMs in group 1 and group 2. Vertical lines on B and D represent the
optimal cutoff (0.61) for classification.
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Fig. 5. The effect of self-mediated positive selection on the recognition of pathogens. (A) The prevalence of np-TCEMs in the proteome of different
pathogens (n = 50). np-TCEMs were defined as being found less than four times in the human proteome or having low expression in cTECs or low thymo-
proteasomal cleavage score. Pathogens are ordered by increasing proteome size. (B) The heatmap shows the prevalence of np-TCEMs in peptides of intra-
cellular pathogens that are presented by common HLA alleles. (C) The plot shows the variance of presented np-TCEMs by different HLA alleles. The variance
decreases with increasing proteome size of pathogens (Spearman’s rho: −0.93, two-sided correlation test P = 9.13*10−23). (D) The fraction of np-TCEMs in
peptides that are presented by risk (n = 6) and protective (n = 7) HLA allele groups. Group-specific values were calculated by averaging values for common
alleles in each group (Methods). In contrast with protective allele groups, predisposing ones present mainly peptides with np-TCEMs in their sequence
(two-sided Wilcoxon’s rank-sum test P = 0.004). HBV: hepatitis B virus; HCV: hepatitis C virus; and HPV: human papillomavirus. For full pathogen names, refer
to Dataset S3.
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future works, whether mutated cancer peptides can also reach this
level of dissimilarity. Similarly, testing our hypothesis on HLA-II
presented peptides and CD4+ T cells is also an important area of
future research.
Methods
Collecting and Filtering Peptide Immunogenicity Data. We collected HLA
binding and T cell activation data from the IEDB (17). The IEDB contains
experimental data on T and B cell epitopes. Data on MHC binding and T cell
specificity are continuously collected from the literature or directly submit-
ted by researchers working in the field. The database is strictly curated and
has a standardized decision algorithm to determine whether a given assay is
positive or not (55, 56). The authors of the database always refer to experts
when they are facing novel assays or immunological content (56). Conse-
quently, the positivity of an assay always means that the interaction be-
tween the adaptive immune receptor and the peptide is highly probable (55,
56). We downloaded raw T cell assay results from the website (as of February
3, 2020). We selected nine and 10 amino acid–long linear nonhuman pep-
tides containing only the 20 standard amino acids and tested for HLA-I al-
leles genotyped with at least 4-digit resolution (SI Appendix, Fig. S1). It is
important to note that the inclusion of human peptides in our analysis could
severely confound our results, because 1) specific positively selected T cells
are more likely to be found for these peptides and 2) they are dominantly
nonimmunogenic due to central and peripheral tolerance mechanisms (16).
Consequently, the presence of human peptides in our datasets could obscure
the effect of T cell–positive selection on peptide immunogenicity. Next, we
created two independent datasets. The first dataset was created using
established methods (5). Specifically, we collected HLA allele–peptide pairs,
in which the binding of the peptide by the HLA allele was supported by the
prediction results of the NetMHCpan-4.0 algorithm (57) (either the binding
affinity was lower than 500 nM, or the binding rank percentile was lower
than 2%) (SI Appendix, Fig. S1). We considered it particularly important to
confirm the HLA-binding of peptides in a unified way using an accurate
algorithm, because especially in older studies, HLA restriction of peptides
was determined with less accurate computational methods.
To avoid the inaccuracy of computational prediction (18, 19), we created
the second dataset using raw MHC binding assay data downloaded from the
IEDB (17) (as of February 3, 2020). We collected allele–peptide pairs that
were found in both MHC binding and T cell assay data at least twice. We
considered a given peptide sequence as being bound by the given HLA allele
if more than 60% of binding assays were positive. We also aimed to exclude
similar sequences from the second dataset. To this end, we used a previously
established iterative method yielding peptides with high sequence diversity
(58). Briefly, the k-tuple distance between all peptide sequences was de-
termined in each iteration using Clustal Omega 1.2 (59). Peptide pair(s) with
the lowest distance values were determined, and the peptide having the
lowest mean distance from all other sequences was excluded. We repeated
these iterations until only peptides with at least 0.5 k-tuple distance from all
other sequences remained in the dataset (60). This distance value corre-
sponds to a maximum 50% overlap between sequences.
In both datasets, we defined allele–peptide pairs with solely negative
T cell assays as nonimmunogenic and the ones with more positive than
negative T cell assays as immunogenic. Allele–peptide pairs not meeting
these criteria were excluded. Peptide sequences tested for multiple alleles
but with the opposite T cell activation results were also excluded (SI Ap-
pendix, Fig. S1). To avoid any overlap between the two datasets, peptides
found in both were only kept in the second one. Using the results of a recent
large immunopeptidomics study (35), we identified HLA alleles, to which
peptides bind with secondary anchor residues in the TCEM region. We
considered a peptide position as an anchoring residue to a given HLA allele
if the amino acid entropy at the position of allele-bound peptides was lower
than 0.8.
Calculating TCEM Frequency, Expression, and the Probability of Thymo- and
Immunoproteasomal Cleavage. According to previous studies (2–5), we de-
fined TCEMs of nine amino acid–long peptides as amino acids from positions
4 through 8. For 10 amino acid–long sequences, we defined TCEMs as amino
acids from positions 5 through 9 according to sequence logos published in a
recent immunopeptidomics study (35). We determined the frequency of
TCEM sequences in human proteins as follows. We downloaded the refer-
ence human proteome from the UniProt database (61) (Proteome ID:
UP000005640; only reviewed sequences are included, downloaded on Jan-
uary, 27th 2020). We decomposed each protein in the proteome to over-
lapping 9-mers, and for each 9-mer, we determined its TCEM sequence (2–5).
We then quantified the incidence of every possible TCEM sequence (n = 205)
in the human proteome.
To calculate the expression of TCEMs in cTECs, we first downloaded gene
expression data of cTECs reported in a recent study (unadjusted counts file
under GEO accession GSE127209) (28). We scaled columns of the count
matrix using the calcNormFactors function in the edgeR R library (62, 63).
Next, we calculated reads per kilobase per million mapped reads (RPKM)
values using the rpkm function of edgeR and exon length data of the
GenomicFeatures R library (64). Then, for each gene, we determined the
median RPKM value in cTEC samples. We matched ENSEMBL gene IDs (used
in the expression dataset) with UniProt IDs as follows. Direct conversion
between IDs was unsatisfactory, as 40% of UniProt protein IDs in the dataset
did not have a corresponding ENSEMBL gene ID in the downloaded ex-
pression set. Consequently, we first converted ENSEMBL gene IDs and Uni-
Prot IDs to Human Genome Organisation (HUGO) IDs using the org.Hs.eg.db
R library and protein information in the UniProt database, respectively.
Next, we matched proteins with genes using HUGO IDs. With this approach,
we were able to determine the expression of encoding genes for more than
90% of proteins. For each TCEM, we first determined genes encoding pro-
teins that include the given TCEM in their sequence and calculated their
median expression. If a given TCEM was found multiple times in the same
protein, we included the expression of the encoding gene the same number
of times in the calculation. We identified TCEMs encoded by housekeeping
genes by using an established list of these genes (65). The relationship be-
tween expression and immunogenicity was plotted using lowess regression
(24) implemented with the Hmisc R library. The probability density of ex-
pression values was plotted after determining the smoothed kernel density
estimate by the ggplot2 R library.
The probability of thymo- and immunoproteasomal cleavage was deter-
mined using amino acid prevalence data around the cleavage site provided
by a previous study (8). Briefly, the authors carried out thymo- and immu-
noproteasomal digestion of three proteins and determined the fraction of
amino acids found at the five positions toward the C and N termini around
the cleavage site. They also provided amino acid frequencies in the three
proteins that would be found if the proteins were randomly cleaved. We
first normalized amino acid prevalence values at each position around the
cleavage site by dividing them with their prevalence in the substrates
yielding amino acid preference scores: ci,j referring to the score of amino acid j
at position i around the cleavage site (i e{ − 5; − 4; − 3; − 2; − 1; 1; 2; 3; 4; 5})
(SI Appendix, Fig. S6A). Next, we determined the probability of proteasomal
cleavage (C) at each site of the human proteome by calculating the median of
ci,j values at positions around the cleavage site (SI Appendix, Fig. S6B). Then,
for each 9-mer peptide in the human proteome, we determined the proba-
bility of peptide formation upon proteasomal cleavage by calculating the
A B C
Fig. 6. The blindness of immune recognition for peptides that are overly
dissimilar to human proteins. (A) The immune system tolerates peptides that
are similar to self-proteins. T cells recognizing these peptides are either
deleted in the thymus or unresponsive due to peripheral tolerance mecha-
nisms (54). (B) Peptides with a certain level of dissimilarity to human proteins
are recognized as nonself resulting in T cell activation and immune-
mediated destruction of cells (Fig. 3B and SI Appendix, Fig. S10). (C) Pep-
tides that are overly dissimilar to human proteins are not recognized by the
immune system, because specific positively selected T cells are absent from
the repertoire (Fig. 3B and SI Appendix, Fig. S10).
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mean of C values (C) at the two sites before the N-terminal and after the
C-terminal amino acids (SI Appendix, Fig. S6C). Finally, for each TCEM, we calcu-
lated the median of C values associated with peptides containing the sequence of
the given TCEM (SI Appendix, Fig. S6D). Note that the presented method was
carried out for thymo- and immunoproteasomal cleavage separately.
For each peptide sequence in the study, the most similar sequence in the
human proteome was identified using BLAST 2.9.0 (66) with the option of
ungapped alignment. The BLOSUM62 similarity between the sequence pairs
was calculated as described previously (54).
Analyzing SARS-CoV-2 TCR Sequencing Dataset. Data on antigen-specific naïve
CD8+ T cells of 27 healthy individuals were downloaded from the website of
Adaptive Biotechnologies (36). The authors cocultured naïve CD8+ T cells of
healthy donors with dendritic cells, loaded with a pool of all examined
peptides of SARS-CoV-2. Then, they used the MIRA technology to identify
antigen-specific T cells. The MIRA technology combines conventional T cell
assays with immune repertoire sequencing to identify a large number of
antigen-specific T cells in the repertoire simultaneously (67). We first de-
termined HLA-I allele–peptide pairs, to which it applies that carrying the
given HLA-I allele could potentially be associated with the prevalence of
specific naïve CD8+ T cells in the repertoire. Specifically, we predicted the
binding of each examined peptide by all HLA alleles carried by any individuals
using NetMHCpan-4.0. We associated the prevalence of T cells with carrying a
given HLA allele if the predicted binding affinity and rank percentile values
suggested strong binding (i.e., affinity was lower than 50 nM, and rank per-
centile was under 0.5%) and peptide-specific T cells were found in at least two
individuals carrying the given allele. We used these strict criteria for HLA-
binding to decrease false positive hits. For each individual, we determined
the peptides, for which we expected to find specific T cells in the repertoire by
considering the previously specified peptide–allele pairs and the HLA geno-
type of the individual. We included a given individual in the analysis only if we
found specific T cells in the repertoire for at least 20 SARS-CoV-2 peptides. This
filtering step yielded data on 22 individuals for further analysis.
Approximating the Level of T Cell Cross-Reactivity. We acquired data on T cell
binding strength reported by two studies (23, 40). Both studies examined the
shift in TCR binding strength when sequentially changing amino acids at
each epitope position. We narrowed down our analysis to the TCEM se-
quence and determined the BLOSUM62 similarity between the TCEM of the
original and the modified peptides as described previously (54). We deter-
mined receiver operating characteristic (ROC) curves and area under the ROC
curve (AUC) values using the ROCR R library (68). The optimal cutoff was
determined using an established cost–benefit method (39) implemented by
the OptimalCutpoints R library (69). In the case of the NY-ESO-1 epitope and
TCR C259, we were able to determine the level of TCR binding strength under
which T cell activation is negligible. We used T cell activation data of the
sequentially modified NY-ESO-1 peptides provided by the same study (23).
We defined lower than 10% of the original epitope’s TCR binding strength
as insufficient binding, because under this value, the median level of T cell
activation was only 7.9% of the original.
Determining TCEMs in Intracellular Pathogens and Analyzing HLA Association
Data. We downloaded the reference proteomes of 50 well-known intracel-
lular pathogens from the UniProt database (61) (on November 18, 2019,
SARS-CoV-2 proteome was downloaded on March 26, 2020; Dataset S3).
First, we determined the TCEMs of each 9-mer in the proteome of each
pathogen. Next, we calculated their prevalence in the human proteome,
expression in cTECs, and probability of proteasomal cleavage as explained
before. We defined np-TCEMs as the ones found less than four times in the
human proteome or having low expression in cTECs or low probability of
thymoproteasomal cleavage. We used cutoff values determined for Fig. 2 to
define low expression and low probability of thymoproteasomal cleavage.
We then predicted the binding of each 9-mer to common HLA alleles with
the NetMHCpan-4.0 algorithm (57). We used HLA-A and B alleles listed in a
reference set with maximal population coverage found on the IEDB web
page (43). As the list did not include data for HLA-C, we selected the first
four-digit alleles from all two-digit HLA-C allele classes. To decrease the
prevalence of false-positive binding results, we considered a 9-mer to be
bound by a given allele if the predicted binding rank percentile value was
under 0.5% and the predicted binding affinity value was under 50 nM. To
those alleles, for which the prediction could not detect any bound peptides
in the proteome of the pathogen, we assigned N peptides having the lowest
predicted binding affinity values, in which N refers to the median number of
peptides bound by other alleles at the same HLA locus. For each allele–
species pair, we calculated the fraction of np-TCEMs in bound peptides and
visualized the results on a heatmap.
To identify HLA allele associations with infectious diseases, we carried out
literature mining. We aimed to involve only reliable HLA association data in
the analysis, so we focused on meta-analyses. We searched PubMed with the
“hla infection meta analysis” and “hla association meta analysis” keywords
on August 27, 2020. We found HLA association meta-analysis studies for
hepatitis B (41), hepatitis C (44), dengue virus (43), and human papilloma-
virus (HPV) (42). In the case of hepatitis B, C, and HPV studies, we selected
significant associations between HLA allele groups and either risk for in-
fections or response to treatment. In the case of dengue virus infection,
P values were not determined by the authors of the study. They ranked as-
sociations of different HLA allele groups with the infection along 17 studies
and considered the allele with the best rank as protective ones. We followed
the method of the authors and carried out the same analysis but considered
only those allele groups that were included in at least 75% of studies to in-
crease the reliability of the analysis. In each study, we calculated the rank
percentile of odds ratio values associated with carrying different allele
groups. Next, we calculated the average of study-specific rank percentile
values for each allele group. We associated the group with the lowest-rank
percentile with protection and the group with the highest-rank percentile
with susceptibility. As the examined meta-analysis studies were carried out
for allele groups or serotypes and not individual alleles, we aggregated the
allele-specific values of np-TCEM presentation as follows. For serotypes, we
averaged the values specific for the alleles that belong to the given serotype.
In the case of allele groups (i.e., HLA type is defined at two-digit resolution),
we averaged the values specific for the alleles that are classified as common
in the Common and Well-Documented Alleles Catalog (70).
Statistical Analysis and Visualization. We used R version 3.6.3 (71) in RStudio
version 1.2.5033 environment for statistical analyses. We used the ggplot2
(72), ggpubr, grid, gridExtra, ggsci, scales, png, ComplexHeatmap (73), and
ggrepel R libraries for visualization. Smooth curves on plots were fitted with
cubic smoothing spline method (74). Figs. 4A and 6 were created with
BioRender.com.
Data Availability. Code data have been deposited in GitHub (https://github.
com/KBalazs1987/ImObsRecognition) and Mendeley Data (https://dx.doi.
org/10.17632/63xr979845.1). All other study data are included in the arti-
cle and/or supporting information. Previously published data were used
for this work (https://www.iedb.org/ and https://adaptivepublic.blob.core.
windows.net/publishedproject-supplements/covid-2020/ImmuneCODE-MIRA-
Release002.zip).
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